Peer-reviewed veterinary case report
Gelatin injections to treat urinary leakage in female dogs
By Chen, Hilla et al.·Published in Journal of veterinary internal medicine·2020·Veterinary Teaching Hospital·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Evaluation of cross-linked gelatin as a bulking agent for the management of urinary sphincter mechanism incompetence in female dogs.
- Species:
- dog
Plain-English summary
Fifteen female dogs with urinary incontinence due to urethral sphincter mechanism incompetence (USMI) were treated with a new bulking agent called VetFoam. This treatment involved injecting VetFoam into the urethra to help improve their ability to hold urine. After the procedure, 87% of the dogs were able to stay dry, and the average duration of this improvement lasted about 11 months. Most dogs showed significant improvement in their continence scores, and only one dog experienced mild side effects that resolved on their own. Overall, VetFoam appears to be a safe and effective option for managing urinary incontinence in female dogs.
People also search for: dog urinary incontinence treatment · VetFoam for dogs · female dog leaking urine · USMI in dogs · urinary sphincter incompetence in dogs
Abstract
BACKGROUND: Bulking agent implantation is a minimally invasive intervention for the management of urethral sphincter mechanism incompetence (USMI). HYPOTHESIS/OBJECTIVES: To evaluate the efficacy and safety of the novel bulking agent VetFoam for the management of urinary incontinence in female dogs diagnosed with USMI. ANIMALS: Fifteen client-owned female dogs. METHODS: Prospective study. Female dogs diagnosed with USMI, refractory, or unamenable to medical treatment were included. VetFoam was injected under endoscopic guidance into the urethral submucosa. Continence score was evaluated before and after the procedure and monthly thereafter. RESULTS: Twenty-two injection procedures were performed in 15 dogs (5 dogs underwent >1 procedure). Median age of all dogs at the time of the procedure was 111 months (range, 18-180). Median continence score significantly increased after, compared with before bulking agent injection (1.5; range, 1.0-3.5 versus 4.0; range, 1.5-5 respectively; P < .001; effect size, 2.6). Continence was achieved in 13/15 (87%) dogs after the first procedure and in 7/7 (100%) repeated procedures. Overall, 20/22 (91%) procedures resulted in high (≥4) continence scores at time of first follow-up. Mean duration of continence was 11.1 months (SD, 10.7) after the first injection. One dog (7%) developed self-limiting stranguria, pollakiuria, and tenesmus while no other apparent adverse effects were recognized in the other dogs. CONCLUSIONS AND CLINICAL IMPORTANCE: VetFoam is an apparently safe, effective novel bulking agent, which can be used as an alternative for the management of USMI.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/32686187/